CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-14 | Bertrand William C JR Chief Operating Officer | Sale | −2,271 | $5.37 | $12K | 3,731 |
| 2019-01-14 | Amado Rafael President, R & D | Sale | −3,028 | $5.37 | $16K | 4,974 |
| 2019-01-14 | Rawcliffe Adrian Chief Financial Officer | Sale | −3,084 | $5.37 | $17K | 3,318 |
| 2018-10-01 | Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | Sale | −25,000 | $13.79 | $345K | 0 |
| 2018-08-29 | Binder-Scholl Gwendolyn Knowlton Chief Technology Officer | Sale | −25,000 | $10.25 | $256K | 0 |
| 2018-06-06 | Thompson Peter A. Director | Sale | −1,600 | $13.49 | $22K | 4,901,310 |
| 2018-06-06 | ORBIMED ADVISORS LLC Director | Sale | −1,600 | $13.49 | $22K | 4,901,310 |
| 2018-06-04 | Thompson Peter A. Director | Sale | −17,100 | $13.57 | $232K | 4,902,910 |
| 2018-06-04 | ORBIMED ADVISORS LLC Director | Sale | −17,100 | $13.57 | $232K | 4,902,910 |
| 2018-06-01 | Thompson Peter A. Director | Sale | −50,000 | $13.49 | $675K | 4,920,010 |
| 2018-06-01 | ORBIMED ADVISORS LLC Director | Sale | −50,000 | $13.49 | $675K | 4,920,010 |
| 2018-05-30 | Thompson Peter A. Director | Sale | −121,000 | $13.52 | $1.6M | 4,970,010 |
| 2018-05-30 | ORBIMED ADVISORS LLC Director | Sale | −121,000 | $13.52 | $1.6M | 4,970,010 |
| 2018-05-14 | Thompson Peter A. Director | Sale | −10,300 | $13.50 | $139K | 5,091,010 |
| 2018-05-14 | ORBIMED ADVISORS LLC Director | Sale | −10,300 | $13.50 | $139K | 5,091,010 |
| 2018-03-29 | Thompson Peter A. Director | Sale | −31,983 | $11.53 | $369K | 5,101,310 |
| 2018-03-29 | ORBIMED ADVISORS LLC Director | Sale | −31,983 | $11.53 | $369K | 5,101,310 |
| 2018-03-27 | Thompson Peter A. Director | Sale | −1,016,084 | $11.50 | $11.7M | 5,133,293 |
| 2018-03-27 | ORBIMED ADVISORS LLC Director | Sale | −1,016,084 | $11.50 | $11.7M | 5,133,293 |
| 2018-03-20 | Rawcliffe Adrian Chief Financial Officer | Sale | −600,000 | $1.71 | $1.0M | 0 |
Page 7 of 7 · 140 trades